Assays for predicting and monitoring responses to lung cancer immunotherapy

Immunotherapy has become a key strategy for cancer treatment, and two immune checkpoints, namely, programmed cell death 1 (PD-1) and its ligand (PD-L1), have recently emerged as important targets. The interaction blockade of PD-1 and PD-L1 demonstrated promising activity and antitumor efficacy in ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Teixidó, Cristina, Karachaliou, Niki, González-Cao, Maria, Morales-Espinosa, Daniela, Rosell, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493376/
https://www.ncbi.nlm.nih.gov/pubmed/26175924
http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493376/
https://www.ncbi.nlm.nih.gov/pubmed/26175924
http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0019

Ejemplares similares